New insights into the pathogenesis of Streptococcus pneumoniae-associated hemolytic uremic syndrome

Rebecca R Scobell,Bernard S Kaplan,Lawrence Copelovitch
DOI: https://doi.org/10.1007/s00467-019-04342-3
Abstract:The purpose of this review is to describe Streptococcus pneumoniae-associated hemolytic uremic syndrome (P-HUS) with emphasis on new insights into the pathophysiology and management over the past 10 years. Even though awareness of this clinico-pathological entity has increased, it likely remains under-recognized. Recent observations indicate that although neuraminidase activity and exposure of the T-antigen are necessary for development of P-HUS, they are not sufficient; activation of the alternate pathway of complement may also contribute. It is unclear, however, whether or not eculizumab and/or plasmapheresis are of value.
What problem does this paper attempt to address?